Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
elraglusib (9-ING-41)
i
Other names:
9-ING-41, 9 ING 41, 9ING41
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Actuate Therap
Drug class:
GSK3β inhibitor
Related drugs:
‹
BCN057 (1)
LY2090314 (0)
BCN057 (1)
LY2090314 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF V600K
Melanoma
BRAF V600K
Melanoma
9-ING-41
Sensitive: C3 – Early Trials
9-ING-41
Sensitive
:
C3
9-ING-41
Sensitive: C3 – Early Trials
9-ING-41
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login